ExoVasc® PEARS

Two significant Milestones

The company has reached two significant milestones in its clinical experience with the ExoVasc® Personalised External Aortic Root Support. In late October the 20th patient received their ExoVasc® support. This month also sees the collective total of post-operative patient experience reach 50 years.

A paper describing the follow up on the first 10 patients has been accepted for publication in the Journal of Interactive CardioVascular and Thoracic Surgery.

Exstent Appoints Matt Thompson as CEO to Drive Global Growth in Personalised Aortic Support

The 11 Beaches Walk raises money for research into cardiovascular disease

Interested in our patient experiences?

We develop medical devices that manage aortic dilation and minimise the risk of aortic dissection.

quick links

statements & policies

Our contact details

The staff of Exstent Limited are not medically qualified and are thus not able to provide clinical advice or answer questions of a clinical nature. We may direct your attention to publications in peer-reviewed journals that provide clinical information or provide information based upon personal experience. However, for any questions of a clinical nature patients are recommended to consult a qualified clinician.